Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
P/S (TTM)
0.3
EV / FCF (TTM)
—
Global Cord Blood Corporation (GCBC), alongside its associated entities, provides specialized services related to umbilical cord blood within the People's Republic of China. The company's operations involve the testing, processing, and long-term storage of cord blood for both private subscribers and donated samples. For the latter, it also facilitates donor matching. As of March 31, 2022, GCBC managed three cord blood banks situated in key regions: Beijing municipality, Guangdong province, and Zhejiang province. The company, which is headquartered in Central, Hong Kong, rebranded as Global Cord Blood Corporation in March 2018, having previously been known as China Cord Blood Corporation. Currently, it functions as a subsidiary under Blue Ocean Structure Investment Company Ltd.
www.globalcordbloodcorp.comNo one on the platform currently holds CO.
No tracked institution reports a position in CO as of their last filing.
No one on the platform has traded CO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| COGlobal Cord Blood Corporation | $2.99 | +0.00% | $400M | — |
| CTEVClaritev Corporation | $35.54 | -2.47% | $606M | — |
| GTHXG1 Therapeutics, Inc. | $7.16 | +0.14% | $378M | — |
| LABStandard BioTools Inc. | $0.69 | -0.89% | $270M | — |
| ORTXOrchard Therapeutics plc | $16.70 | +0.30% | $380M | — |
| RVNCRevance Therapeutics, Inc. | $3.65 | +0.00% | $381M | — |
| SLGCSomaLogic, Inc. | $2.10 | -4.55% | $396M | — |
Source: Financial Modeling Prep · peers by sector/industry